Imaging of hepatic metastases

Cancer Control

Volumn 13, Issue 1, 2006, Pages 6-12

  Choi, Junsung ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; MANGAFODIPIR; SUPERPARAMAGNETIC IRON OXIDE;

CANCER CHEMOTHERAPY; CANCER SCREENING; CHEMOEMBOLIZATION; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DECISION MAKING; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIAPHRAGM; DRUG UPTAKE; ECHOGRAPHY; FOLLOW UP; HUMAN; IMAGING; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PATIENT SELECTION; PORTAL PHLEBOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; REVIEW; TREATMENT PLANNING;

EID: 33644649762     PISSN: 10732748     EISSN: 15262359     Source Type: Journal    
DOI: 10.1177/107327480601300102     Document Type: Review

References (44)

1. Bengmark S, Hafstrom L, Olssen A, et al. The natural history of primary and secondary liver tumours. V. The prognosis for conventionally treated patients with liver metastases. Digestion. 1972;6:321-329.
2. American Cancer Society. Cancer Facts and Figures, 1999. Atlanta, Ga: American Cancer Society; 1999.
3. Sugarbaker PH. Surgical decision making for large bowel cancer metastatic to the liver. Radiology. 1990;174(3 pt 1):621-626.
4. Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol. 1997;15:938-946.
5. Di Stefano DR, de Baere T, Denys A, et al. Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients. Radiology. 2005;234:625-630. Epub 2004 Dec 10.
6. Kamel IR, Kruskal JB, Warmbrand G, et al. V Accuracy of volumetric measurements after virtual right hepatectomy in potential donors undergoing living adult liver transplantation. AJR Am J Roentgenol. 2001;176:483-487.
7. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205-216.
8. Kamel IR, Georgiades C, Fishman EK. Incremental value of advanced image processing of multislice computed tomography data in the evaluation of hypervascular liver lesions. J Comput Assist Tomogr. 2003;27:652-656.
9. Sahani D, Mehta A, Blake M, et al. Preoperative hepatic vascular evaluation with CT and MR angiography: implications for surgery. Radiographics. 2004;24:1367-1380.
10. Hollett MD, Jeffrey RB Jr, Nino-Murcia M, et al. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms. AJR Am J Roentgenol. 1995;164:879-884.
11. Bonaldi VM, Bret PM, Reinhold C, et al. Helical CT of the liver: value of an early hepatic arterial phase. Radiology. 1995;197:357-363.
12. Soyer P, Poccard M, Boudiaf M, et al. Detection of hypovascular hepatic metastases at triple-phase helical CT: sensitivity of phases and comparison with surgical and histopathologic findings. Radiology. 2004;231:413-420. Epub 2004 Mar 24.
13. Haider MA, Amitai MM, Rappaport DC, et al. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? Radiology. 2002;225:137-142.
14. Kinkel K, Lu Y, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology. 2002;224:748-756.
15. Bhattacharjya S, Bhattacharjya T, Baber S, et al. Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection. Br J Surg. 2004;91:1361-1369.
16. Bluemke DA, Soyer PA, Chan BW, et al. Spiral CT during arterial portography: technique and applications. Radiographics. 1995;15:623-639.
17. Erratum in: Radiographics. 1995;15:1190.
18. Soyer P, Levesque M, Elias D, et al. Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology. 1992;183:541-544.
19. Vogel SB, Drane WE, Ros PR, et al. Prediction of surgical resectability in patients with hepatic colorectal metastases. Ann Surg. 1994;219:508-516.
20. Karl RC, Choi J, Yeatman TJ, et al. Role of computed tomographic arterial portography and intraoperative ultrasound in the evaluation of patients for resectability of hepatic lesions. J Gastrointest Surg. 1997;1:152-158.
21. Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol. 2003;13:262-272. Epub 2002 Sep 10.
22. Takahashi K, Furuse M, Saito K, et al. Intraarterial digital subtraction angiography in detection of HCC. Cardiovasc Intervent Radiol. 1989;12:61-65.
23. Hagspiel KD, Neidl KF, Eichenberger AC, et al. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology. 1995;196:471-478.
24. Eberhardt SC, Choi PH, Bach AM, et al. Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med. 2003;22:335-343; quiz 345-346.
25. Rickes S, Ocran KW, Gerstenhauer G, et al. Evaluation of diagnostic criteria for liver metastases of adenocarcinomas and neuroendocrine tumours at conventional ultrasound, unenhanced power Doppler sonography and echo-enhanced ultrasound. Dig Dis. 2004;22:81-86.
26. Isozaki T, Numata K, Kiba T, et al. Differential diagnosis of hepatic tumors by using contrast enhancement patterns at US. Radiology. 2003;229:798-805. Epub 2003 Oct 16.
27. Albrecht T, Hohmann J, Oldenburg A, et al. Detection and characterisation of liver metastases. Eur Radiol. 2004;14(suppl 8):P25-P33.
28. Vidiri A, Carpanese L, Annibale MD, et al. Evaluation of hepatic metastases from colorectal carcinoma with MR-superparamagnetic iron oxide. J Exp Clin Cancer Res. 2004;23:53-60.
29. Numminen K, Isoniemi H, Halavaara J, et al. Preoperative assessment of focal liver lesions: multidetector computed tomography challenges magnetic resonance imaging. Acta Radiol. 2005;46:9-15.
30. Kostakoglu L, Agress H Jr, Goldsmith SJ, et al. Clinical role of FDG PET in evaluation of cancer patients. Radiographics. 2003;23:315-340; quiz 533.
31. Rohren EM, Turkington TG, Coleman RE. Clinical applications of PET in oncology. Radiology. 2004;231:305-332. Epub 2004 Mar 24.
32. Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol. 2001;11:1968-1974.
33. Yau YY, Chan WS, Tam YM, et al. Application of intravenous contrast in PET/CT: does it really introduce significant attenuation correction error? J Nucl Med. 2005:46:283-291.
34. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology. 1998;206:755-760.
35. Arulampalam TH, Francis DL, Visvikis D, et al. FDG-PET for the preoperative evaluation of colorectal liver metastases. Eur J Surg Oncol. 2004;30:286-291.
36. Fong Y, Saldinger PF, Akhurst T, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg. 1999;178:282-287.
37. Delbeke D, Vitola JV, Sandler MP, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med. 1997;38:1196-1201.
38. Rohren EM, Paulson EK, Hagge R, et al. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med. 2002;27:550-555.
39. Henn AR, Levine EA, McNulty W, et al. Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes. AJR Am J Roentgenol. 2003;181:1005-1010.
40. Goldberg SN, Gazelle GS, Compton CC et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation. Cancer. 2000;88:2452-2463.
41. Limanond P, Zimmerman P, Raman SS, et al. Interpretation of CT and MRI after radiofrequency ablation of hepatic malignancies. AJR Am J Roentgenol. 2003;181:1635-1640.
42. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255-262.
43. Antoch G, Vogt FM, Veit P, et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med. 2005;46:520-525.
44. Anderson GS, Brinkmann F, Soulen MC, et al. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med. 2003;28:192-197.